Fir Tree Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-173,034
Closed -$1.78M – 279
2023
Q2
$1.78M Sell
173,034
-2,048
-1% -$20.9K 0.17% 187
2023
Q1
$1.77M Buy
175,082
+100,862
+136% +$1.02M 0.14% 201
2022
Q4
$742K Sell
74,220
-1,523
-2% -$15K 0.04% 304
2022
Q3
$734K Hold
75,743
– – 0.02% 407
2022
Q2
$734K Sell
75,743
-2,034
-3% -$19.8K 0.02% 432
2022
Q1
$758K Buy
+77,777
New +$751K 0.02% 436

Fir Tree Capital Management's DALS Position: Q3 2023 in Review

Fir Tree Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 173,034 shares — an estimated $1.78M sold.

Fir Tree Capital Management first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $1.78M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Fir Tree Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Fir Tree Capital Management sold 173,034 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $1.78M.
  • Fir Tree Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2022 and held it in 6 quarters.
  • Fir Tree Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $1.78M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Fir Tree Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.